New China:US preclinical partnership formed
02-Jan-2008 - US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services,...
A drug cocktail to bust brain tumours
02-Jan-2008 - A team of US researchers have uncovered a cocktail of three drugs that could be...
New drug target leaves lung cancer cells alone, lonely and dying
02-Jan-2008 - It seems even tumour cells can get lonely; scientists have discovered that by cutting off...
More pharmas implicated in Iraq bribery probe
02-Jan-2008 - While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud...
IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration
02-Jan-2008 - Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving...
New drug on the blocks for athletes
19-Dec-2007 - Scientists have discovered a potential new drug target that will prick up the ears of...
Pfizer buys CovX to bulk biologics pipeline
19-Dec-2007 - Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a...
Semen fibrils ferry HIV into cells
17-Dec-2007 - Tiny protein fibres in semen have been found to enhance the ability of HIV to...
Shire snaps up Alba's gastrointestinal drug for $325m
17-Dec-2007 - US biopharma firm Alba Therapeutics has received a boost to its coffers after Shire agreed...
New cell line to tackle drug resistant cancer
13-Dec-2007 - The creation of a new 'super cell' that can stand firm against one of the...
Galapagos branches out with new GSK deal
10-Dec-2007 - GlaxoSmithKline (GSK) is the latest drug firm to involve Galapagos in a new development partnership,...
Drugs moving into the clinic: 37
04-Dec-2007 - The latest in a series of periodic roundups of drugs that have moved from preclinical...
Almirall takes on big pharma in COPD
03-Dec-2007 - Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined...
Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline
03-Dec-2007 - Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline...
Xenome and Amylin team up to poison metabolic diseases
27-Nov-2007 - Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned...
Astellas snaps up cancer antibody specialists Agensys
27-Nov-2007 - Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its...
Targeted Genetics restarts trial after death
26-Nov-2007 - The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis...
Merck, Vertex halt aurora kinase cancer trial
22-Nov-2007 - Merck & Co. and its partner Vertex Pharmaceuticals have stopped enrolling cancer patients to the...
Take off immune system brake to improve cancer vaccines
22-Nov-2007 - The discovery of a new molecule that can act as a brake for the immune...
Mr Gene designs and orders constructs in minutes
22-Nov-2007 - Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr...
Drugs moving into the clinic: 36
22-Nov-2007 - The latest in a series of periodic roundups of drugs that have moved from preclinical...
Weekly Comment
No embryo required: human stem cells from the skin
21-Nov-2007 - A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin...
Men get the heads up on possible oral contraceptive
21-Nov-2007 - It might be years away yet, but men could be the ones popping a pill...
Cystatin C can wash away Alzheimer's plaques
20-Nov-2007 - Scientists have discovered that a protein called cystatin C can prevent damaging Alzheimer's plaques from...
Cancer antibody marches on quoths Raven Biotechnologies
20-Nov-2007 - Raven Biotechnologies have announced positive initial clinical trial results for their anticancer antibody that causes...
